{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:03:14Z","timestamp":1792249394163,"version":"4.4.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/mao.0b013e3182898272","type":"journal-article","created":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T11:19:54Z","timestamp":1369912794000},"page":"961-970","source":"Crossref","is-referenced-by-count":22,"title":["A Comprehensive Network and Pathway Analysis of Human Deafness Genes"],"prefix":"10.1097","volume":"34","author":[{"given":"Georgios A.","family":"Stamatiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina M.","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-29-20210212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.1991.tb19572.x","article-title":"Genetic epidemiology of hearing impairment.","volume":"630","author":"Morton","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"R4-29-20210212","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/bmb\/63.1.73","article-title":"Hereditary deafness and phenotyping in humans.","volume":"63","author":"Bitner-Glindzics","year":"2002","journal-title":"Br Med Bull"},{"key":"R5-29-20210212","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000074183","article-title":"Deafness genes and their diagnostic applications.","volume":"9","author":"Cryns","year":"2004","journal-title":"Audiol Neurootol"},{"key":"R7-29-20210212","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1525-1578(10)60522-3","article-title":"Hereditary non-syndromic sensorineural hearing loss: transforming silence to sound.","volume":"6","author":"Schrijver","year":"2004","journal-title":"J Mol Diagn"},{"key":"R8-29-20210212","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.genom.4.070802.110347","article-title":"Human nonsyndromic sensorineural deafness.","volume":"4","author":"Friedman","year":"2003","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"R9-29-20210212","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/gb-2009-10-9-r91","article-title":"Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network.","volume":"10","author":"Linghu","year":"2009","journal-title":"Genome Biol"},{"key":"R11-29-20210212","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2307\/2340521","article-title":"On the interpretation of x2 from contingency tables, and the calculation of P.","volume":"85","author":"Fisher","year":"1922","journal-title":"J R Stat Soc"},{"key":"R13-29-20210212","doi-asserted-by":"crossref","first-page":"10903","DOI":"10.1523\/JNEUROSCI.2358-11.2011","article-title":"Developmental profiling of spiral ganglion neurons reveals insights into auditory circuit assembly.","volume":"31","author":"Lu","year":"2011","journal-title":"J Neurosci"},{"key":"R14-29-20210212","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00125817-200207000-00004","article-title":"GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review.","volume":"4","author":"Kenneson","year":"2002","journal-title":"Genet Med"},{"key":"R15-29-20210212","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/374060a0","article-title":"Defective myosin VIIA gene responsible for Usher syndrome type 1B.","volume":"374","author":"Weil","year":"1995","journal-title":"Nature"},{"key":"R16-29-20210212","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng0697-188","article-title":"Mutations in the myosin VIIA gene cause non-syndromic recessive deafness.","volume":"16","author":"Liu","year":"1997","journal-title":"Nat Genet"},{"key":"R17-29-20210212","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1297-411","article-title":"Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS).","volume":"17","author":"Everett","year":"1997","journal-title":"Nat Genet"},{"key":"R18-29-20210212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng0398-215","article-title":"A mutation in PDS causes non-syndromic recessive deafness.","volume":"18","author":"Li","year":"1998","journal-title":"Nat Genet"},{"key":"R19-29-20210212","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00439-001-0644-8","article-title":"Phenotypic variability at the TGF-beta-1 locus in Camurati-Engelmann disease.","volume":"109","author":"Campos-Xavier","year":"2001","journal-title":"Hum Genet"},{"key":"R20-29-20210212","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/ddm150","article-title":"The coding polymorphism T263I in TGF-b1 is associated with otosclerosis in two independent populations.","volume":"16","author":"Thys","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R21-29-20210212","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/er.2004-0001","article-title":"Transforming growth factor-beta1 to the bone.","volume":"26","author":"Janssens","year":"2005","journal-title":"Endocr Rev"},{"key":"R22-29-20210212","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0012-1606(92)90117-Y","article-title":"Transforming growth factor beta 1 is an epithelial-derived signal peptide that influences otic capsule formation.","volume":"153","author":"Frenz","year":"1992","journal-title":"Dev Biol"},{"key":"R23-29-20210212","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-291X(89)92795-2","article-title":"Activation of the bone-derived latent Tgf beta-complex by isolated osteoclasts.","volume":"158","author":"Oreffo","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-29-20210212","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ajhg.2007.09.023","article-title":"Mutations in BMP4 cause eye, brain, and digit developmental anomalies: overlap between the BMP4 and hedgehog signaling pathways.","volume":"82","author":"Bakrania","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R25-29-20210212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-387025-4.00006-6","article-title":"Aromatase activity and bone loss.","volume":"54","author":"Gennari","year":"2011","journal-title":"Adv Clin Chem"},{"key":"R26-29-20210212","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1006\/bbrc.1995.2647","article-title":"17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro.","volume":"216","author":"Behl","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"R27-29-20210212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/00016480510038617","article-title":"Estrogen and hearing: a summary of recent investigations.","volume":"126","author":"Hultcrantz","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"R28-29-20210212","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","article-title":"Opposing effects of ERK and JNK-p38MAPkinases on apoptosis.","volume":"270","author":"Xia","year":"1995","journal-title":"Science"},{"key":"R29-29-20210212","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1523\/JNEUROSCI.5338-05.2006","article-title":"Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival.","volume":"26","author":"Arthur","year":"2006","journal-title":"J Neurosci"},{"key":"R30-29-20210212","first-page":"153","article-title":"Mitogen activated protein (MAP) kinase pathways: regulation and physiological functions.","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr Rev"},{"key":"R32-29-20210212","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.neuroscience.2003.08.041","article-title":"Involvement of ras activation in toxic hair cell damage of the mammalian cochlea.","volume":"122","author":"Battaglia","year":"2003","journal-title":"Neuroscience"},{"key":"R33-29-20210212","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1523\/JNEUROSCI.4914-07.2008","article-title":"Damaged-induced activation of ERK 12 in cochlear supporting cells is a hair cell death-promoting signal that depends on extracellular ATP and calcium.","volume":"28","author":"Lahne","year":"2008","journal-title":"J Neurosci"},{"key":"R34-29-20210212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BJ20100458","article-title":"Exploring a role for heteromerization in GPCR signalling specificity.","volume":"433","author":"Rozenfeld","year":"2010","journal-title":"Biochem J"},{"key":"R35-29-20210212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/me.2009-0473","article-title":"The year in G protein-coupled receptor research.","volume":"24","author":"Millar","year":"2010","journal-title":"Mol Endocrinol"},{"key":"R36-29-20210212","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/978-1-4419-7913-1_6","article-title":"Studies on the very large G protein-coupled receptor: from initial discovery to determining its role in sensorineural deafness in higher animals.","volume":"706","author":"McMillan","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"R37-29-20210212","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/MCB.16.3.925","article-title":"Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes.","volume":"16","author":"Drewes","year":"1996","journal-title":"Mol Cell Biol"},{"key":"R38-29-20210212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-1336-1-5","article-title":"Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4alpha (HNF4alpha) isoforms in humans and rats.","volume":"1","author":"Jiang","year":"2003","journal-title":"Nucl Recept"},{"key":"R39-29-20210212","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/MCB.21.4.1393-1403.2001","article-title":"Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.","volume":"21","author":"Hayhurst","year":"2001","journal-title":"Mol Cell Biol"},{"key":"R40-29-20210212","doi-asserted-by":"crossref","first-page":"25257","DOI":"10.1074\/jbc.M203126200","article-title":"Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4alpha (HNF4alpha). HNF4alpha regulates ornithine transcarbamylase in vivo.","volume":"277","author":"Inoue","year":"2002","journal-title":"J Biol Chem"},{"key":"R41-29-20210212","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1074\/jbc.M311015200","article-title":"Hepatocyte nuclear factor 4alpha is a central regulator of bile acid conjugation.","volume":"279","author":"Inoue","year":"2004","journal-title":"J Biol Chem"},{"key":"R42-29-20210212","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00109-005-0013-5","article-title":"Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression.","volume":"84","author":"Inoue","year":"2006","journal-title":"J Mol Med"},{"key":"R43-29-20210212","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1172\/JCI200522365","article-title":"The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion.","volume":"115","author":"Gupta","year":"2005","journal-title":"J Clin Invest"},{"key":"R44-29-20210212","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00005537-200209000-00019","article-title":"Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation.","volume":"112","author":"Satoh","year":"2002","journal-title":"Laryngoscope"},{"key":"R45-29-20210212","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/000348947908800501","article-title":"Autoimmune sensorineural hearing loss.","volume":"88","author":"McCabe","year":"1979","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R46-29-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-199907001-00001","article-title":"Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application.","volume":"109","author":"Parnes","year":"1999","journal-title":"Laryngoscope"},{"key":"R47-29-20210212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.amjmed.2009.08.006","article-title":"Analgesic use and the risk of hearing loss in men.","volume":"123","author":"Curhan","year":"2010","journal-title":"Am J Med"},{"key":"R48-29-20210212","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/aje\/kws146","article-title":"Analgesic use and the risk of hearing loss in women.","volume":"176","author":"Curhan","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R49-29-20210212","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/lary.20511","article-title":"Sudden hearing loss from PDE-5 inhibitors: a possible cellular stress etiology.","volume":"119","author":"Maddox","year":"2009","journal-title":"Laryngoscope"},{"key":"R50-29-20210212","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/labinvest.3700669","article-title":"Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations.","volume":"87","author":"Prudhomme","year":"2007","journal-title":"Lab Invest"},{"key":"R51-29-20210212","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.ki.5001846","article-title":"Renal injury due to rennin-angiotensin-aldosterone sysyem activation of the transforming growth factor-beta pathway.","volume":"70","author":"Wolf","year":"2006","journal-title":"Kidney Int"},{"key":"R52-29-20210212","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.2174\/092986706779026138","article-title":"Impact of inhibitors of the renin-angiotensin-aldosterone system on liver fibrosis and portal hypertension.","volume":"13","author":"Tox","year":"2006","journal-title":"Curr Med Chem"},{"key":"R53-29-20210212","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000090140","article-title":"Losartan attenuates bleomycin induced pulmonary fibrosis in rats.","volume":"73","author":"Yao","year":"2006","journal-title":"Respiration"},{"key":"R54-29-20210212","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling.","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R55-29-20210212","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states.","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat Med"},{"key":"R57-29-20210212","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1046\/j.1523-1755.2000.07714.x","article-title":"Effect of lovastatin on small GTP binding proteins an on TGF-beta1 and fibronectin expression.","volume":"77","author":"Kim","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"R58-29-20210212","doi-asserted-by":"crossref","first-page":"L1323","DOI":"10.1152\/ajplung.00447.2003","article-title":"Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism.","volume":"287","author":"Watts","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R59-29-20210212","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/ndt\/gfh859","article-title":"Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral uteral obstruction.","volume":"20","author":"Vieira","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R60-29-20210212","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cytogfr.2007.04.005","article-title":"TGF-beta1: a novel target for cardiovascular pharmacology.","volume":"18","author":"Redondo","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"R61-29-20210212","first-page":"166","article-title":"Pirfenidone.","volume":"7","author":"Lasky","year":"2004","journal-title":"IDrugs"},{"key":"R62-29-20210212","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1517\/13543784.15.7.823","article-title":"Pirfenidone for the treatment of idiopathic pulmonary fibrosis.","volume":"15","author":"Antoniu","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"R63-29-20210212","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1022951824806","article-title":"Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.","volume":"2","author":"Wojtowicz-Praga","year":"2003","journal-title":"Invest New Drugs"},{"key":"R64-29-20210212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1081\/IPH-120020473","article-title":"Minimal effects on immune parameters following chronic anti-TGF-beta monoclonal antibody administration to normal mice.","volume":"25","author":"Ruzek","year":"2003","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R65-29-20210212","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1158\/0008-5472.CAN-04-3272","article-title":"Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.","volume":"65","author":"Forrester","year":"2005","journal-title":"Cancer Res"},{"key":"R66-29-20210212","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0006-291X(03)00670-3","article-title":"Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase -3-9-14 and CD44.","volume":"304","author":"Tanimura","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R67-29-20210212","first-page":"219","article-title":"Pharmacological inhibitors of the ERK signaling pathway: applications as anticancer drugs.","volume":"5","author":"Kohno","year":"2003","journal-title":"Prog Cell Cycle Res"},{"key":"R68-29-20210212","doi-asserted-by":"crossref","first-page":"e4662","DOI":"10.1371\/journal.pone.0004662","article-title":"HNF4alpha and HNF1alpha dysfunction as a molecular rational for cyclosporine induced posttransplantation diabetes mellitus.","volume":"4","author":"Borlak","year":"2009","journal-title":"PLoS ONE"},{"key":"R69-29-20210212","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/00016480410016225","article-title":"Progressive sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis.","volume":"124","author":"Marioni","year":"2004","journal-title":"Acta Otolaryngol"},{"key":"R70-29-20210212","first-page":"289","article-title":"Tumor suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4 (HNF4) gene.","volume":"415","author":"Maeda","year":"2008","journal-title":"Biochem J"},{"key":"R71-29-20210212","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/BJ20080355","article-title":"Modulation of hepatocyte nuclear factor-4a function by the peroxisome-proliferator-activated receptor- co-activator-1 in the acute phase response.","volume":"415","author":"Wang","year":"2008","journal-title":"Biochem J"},{"key":"R72-29-20210212","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/me.2007-0531","article-title":"Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.","volume":"23","author":"Xie","year":"2009","journal-title":"Mol Endocrinol"}],"container-title":["Otology & Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAO.0b013e3182898272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:07:04Z","timestamp":1620958024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129492-201307000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e3182898272","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}